Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Caenorhabditis elegans as a possible model to screen anti-Alzheimer's therapeutics

20 Oct 2020

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholinesterase and Neurodegenerative Diseases
Share to Genetics, Aging, and Longevity in Model Organisms
Share to Medicinal Plants and Bioactive Compounds

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33091537
DOI: 10.1016/j.vascn.2020.106932

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Caenorhabditis elegans as a possible model to screen anti-Alzheimer's therapeuticsPMID 33091537Read ↗

Caenorhabditis elegans as a model system for target identification and drug screening against neurodegenerative diseasesSemantic proximity Read ↗

Understanding the molecular basis of Alzheimer’s disease using a Caenorhabditis elegans model systemSemantic proximity Read ↗

Alzheimer's disease drug discovery: in vivo screening using Caenorhabditis elegans as a model for β-amyloid peptide-induced toxicitySemantic proximity Read ↗

Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson’s disease, Alzheimer’s disease and autism spectrum disorderSemantic proximity Read ↗

Modeling Alzheimer’s Disease in Caenorhabditis elegansSemantic proximity Read ↗

Natural Bioactive Products and Alzheimer’s Disease Pathology: Lessons from Caenorhabditis elegans Transgenic ModelsSemantic proximity Read ↗

Caenorhabditis elegans as an emerging high throughput chronotherapeutic drug screening platform for human neurodegenerative disordersSemantic proximity Read ↗

Utility of an improved model of amyloid-beta (Aβ1-42) toxicity in Caenorhabditis elegans for drug screening for Alzheimer’s diseaseSemantic proximity Read ↗

Use of Caenorhabditis elegans as a model to study Alzheimer’s disease and other neurodegenerative diseasesSemantic proximity Read ↗

Drug discovery: Insights from the invertebrate Caenorhabditis elegansSemantic proximity Read ↗

Towards Understanding Neurodegenerative Diseases: Insights from Caenorhabditis elegansSemantic proximity Read ↗

Exploring Caenorhabditis elegans as Parkinson’s Disease Model: Neurotoxins and Genetic ImplicationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.